This study has some limitations: there lacks clinical evidence that lung cancer tissues from NSCLC patients with OSA present a higher Bach1 expression and lung CSC properties than those from NSCLC patients without OSA. The gene discussed is BACH1; the disease is non-small cell lung carcinoma.